Otolaryngology (ENT)
ENT Clinical Research
ENT disorders impact millions worldwide, affecting breathing, hearing, and quality of life. CenExel partners with sponsors to advance innovative ENT therapies through precise, patient-focused clinical research across diverse populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading ENT Clinical Research
Complex ENT trials require specialized expertise and advanced diagnostic capabilities. CenExel’s experienced teams support studies across ear, nose, and throat conditions — ensuring high-quality data and efficient execution from first-patient-in to last-patient-out.
Our sites integrate clinical expertise with cutting-edge tools to evaluate outcomes in respiratory, auditory, and sinus-related disorders.
We support a wide range of ENT conditions including sinusitis, hearing disorders, sleep apnea, and rare otolaryngology indications across adult and pediatric populations.
Conditions Covered
ENT Conditions We Research
Our ENT research sites support a broad spectrum of conditions — from common sinus and allergy disorders to complex hearing and airway diseases.
Chronic Sinusitis
Allergic Rhinitis
Nasal Polyps
Obstructive Sleep Apnea (OSA)
Tonsillitis
Hearing Loss
Tinnitus
Otitis Media
Deviated Septum
Laryngitis
Our Approach
Why Sponsors Choose CenExel for ENT
Our ENT expertise extends beyond patient enrollment—we deliver specialized clinical insight, streamlined operations, and high-quality data to support successful outcomes and regulatory confidence across ear, nose, and throat studies.
01
Specialized ENT Expertise
Our investigators and site teams have deep experience in ENT trials, ensuring accurate diagnosis and high-quality data collection.
02
Advanced Diagnostics
We utilize modern tools including imaging, endoscopy, and audiology testing to support precise clinical evaluations.
03
Diverse Patient Access
Access to broad and diverse patient populations enables faster recruitment and real-world representation.
04
Efficient Enrollment
Our recruitment strategies consistently meet enrollment goals with speed and accuracy.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase ENT clinical trials — from first-in-human studies through Phase IV post-market research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
View More
Therapeutic Area
Gastroenterology
In the U.S., millions of patients are affected by gastrointestinal disorders, ranging from chronic conditions like IBS and IBD
Therapeutic Area
Neurology
Neurological disorders affect millions worldwide, creating a critical need for innovative research and advanced treatments.
Therapeutic Area
Metabolic
CenExel partners with pharmaceutical and biotechnology sponsors to accelerate obesity, diabetes, and metabolic